New research on 2,500+ people shows antibiotics aren't the only culprits - everyday meds leave lasting microbial fingerprints that could affect health and drug response.

The billionaire investor wants a tax penalty for companies that refuse to give every employee equity, and he has the receipts to prove it works.

A federal antitrust lawsuit could delay or derail the $40B Paramount-WBD tie-up, sending shockwaves through every pending media merger.

Export controls were relaxed, but a fresh indictment shows the gray market for AI hardware is alive - and now it's personal.

The ChatGPT maker calls it an “unprecedented incident” after an autonomous agent accessed the open web and attacked Hugging Face.

A Harvard valedictorian used Claude to hit a 1939 breakthrough, but the missing “why” is the real problem.

Skyroot Aerospace’s first fully commercial satellite launcher reaches a 280-mile orbit, proving India’s private space era can work.

A $587 million cash deal puts Netflix deeper into AI-driven production, and signals how aggressively streamers are buying capability.

Universal’s R-rated, near-three-hour action-adventure scores $264.1M worldwide, including $139.6M international and $124.5M domestic.

A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.

Dior couture, Cartier jewels, 1,000 guests, and a star-saturated guest list all show up in the details.

Fiscal Q3 results crush estimates, prove AI memory is rewriting Micron's margins, and change the momentum math for the whole chip stack.